Compounds and methods for the treatment of ERB B2/NEU positive diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9737616
SERIAL NO

14802900

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are anti-ERB B2/NEU antibodies conjugated with maytansinoid drugs for targeted delivery to disease tissues. Methods relating to the preparation and uses of such drug conjugates to treat ERB B2/NEU positive cells in cancers are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIO-THERA SOLUTIONS LTDA6-5FL 11 KAIYUAN AVENUE SCIENCE CITY HIGH-TECH INDUSTRIAL DEVELOPMENT ZONE GUANGZHOU 510530

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Deng, Xiaobin Guangzhou, CN 9 41
Li, Shengfeng Belmont, US 46 222
Tang, Weijia Guangzhou, CN 17 57
Yu, Jin-Chen Palo Alto, US 26 16

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 22, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 22, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00